NIH-funded research R01 grant

How mitochondrial function affects the blood-brain barrier and mental health conditions

Official title: Mitochondrial influences on blood brain barrier function and neuropsychiatric illness

Funded at University of Pennsylvania · NIH-11062466 · Data updated 2026-11-12

This study is looking at how energy problems in cells might affect the protective barrier in the brain for people with 22q11.2 deletion syndrome, and it hopes to find out if fixing these energy issues can help improve brain health and reduce symptoms.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 1, 2024
Project endOctober 31, 2027
Funding year2025
Award (this year)$572,619
NIH project number5R01MH134893-02
Project IDNIH-11062466 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with 22q11.2 deletion syndrome or related neuropsychiatric conditions.

Less likely to help

Patients without 22q11.2 deletion syndrome or those with unrelated neuropsychiatric disorders may not benefit from this research.

What this research studies

This research investigates the relationship between mitochondrial function and the blood-brain barrier (BBB) in patients with 22q11.2 deletion syndrome, a genetic condition linked to neuropsychiatric disorders. The study aims to understand how compromised mitochondrial energetics may lead to BBB dysfunction, which could exacerbate neuroinflammatory processes affecting brain health. By using advanced cell models and animal studies, the researchers will explore whether improving mitochondrial function can restore BBB integrity and potentially alleviate symptoms associated with this syndrome.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies targeting mitochondrial function to improve brain health in patients with neuropsychiatric disorders.

How similar studies have gone: Preliminary data suggests that targeting mitochondrial function to improve BBB integrity has shown promise, indicating that this approach may be a novel and potentially effective strategy.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Alvarez, Jorge Ivan — University of Pennsylvania
  • Study coordinator: Alvarez, Jorge Ivan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.